FTC 'Close' To Final PBM Insulin Price Deal With OptumRx

By Bryan Koenig · May 20, 2026, 4:38 PM EDT

Federal Trade Commission staffers have signaled that they're near a settlement with UnitedHealth Group Inc.'s OptumRx that would close out the agency's in-house case accusing pharmacy benefit managers of inflating insulin...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Express Scripts, Inc., et al v. FTC, et al

Case Number

25-1383

Court

Appellate - 8th Circuit

Nature of Suit

3890 Other Statutory Actions

Date Filed

February 24, 2025